ReachMD CME

First-line Chemotherapy Options in Metastatic PDAC

First-line Chemotherapy Options in Metastatic PDAC

Second-line Chemotherapy Options in Metastatic PDAC

Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies

The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC

Effective Monitoring and Management of Adverse Effects in Metastatic ESCC

Mutational Testing in mCRC: Methods and Data Driving Treatment Selection

From Guidelines to Practice: First-Line Treatment Choices in mCRC

Defining the Standard of Care and Optimal Sequencing in BRAF-Mutant mCRC: Second Line and Beyond

Proactive Adverse Effect Management in mCRC: Improving Tolerability to Optimize Patient Outcomes

Case Consult: Adverse Effect Monitoring, Management, and Mitigation During Targeted Therapy for BRAF-Mutant mCRC

Progress in Breast Cancer Care: Translating SABCS Data Into Practice

Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages

Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens

Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients

Diagnosing IBD: Is It IBD or Something Else? Can You Tell?

Severity Assessment: Can You Pin the Stage on the Patient?

IBD Immunopathogenesis: Do You Know What You're Blocking?

Tailoring Treatment: Can You Select the Best Therapy?

Case Review: Can You Crack This IBD Case?

Remission: Can You Prove It?

Switching Strategies: Switch or Stay—What’s Your Call?

Case Review: Targets Are Met—Can You Stick the Landing?

Treat-to-Target: Are We There Yet?

Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE

When Topicals Fail: The New IPC Consensus Every Clinician Should Know

New Pathways in the Treatment of DMD

Optimizing Multidisciplinary Approaches in the Guideline-Driven Management of Cervical and Endometrial Cancers

Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis

The Tumor That’s Not So Tiny: Understanding the Impact of TGCT

Beyond the Scalpel: When TGCT Surgery Isn’t the Solution

Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices

Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R

Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT

Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs

Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians

The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT

All Sides of the Joint: Integrated TGCT Care Across Specialties

Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy

Minimal Hepatic Encephalopathy: Hiding in Plain Sight?

Minimal Hepatic Encephalopathy: A Covert Operation?

The Slippery Slope of Overt Hepatic Encephalopathy

Treatment of Hepatic Encephalopathy: When, What, How, and Why?

Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis

Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy

Hepatic Encephalopathy: More Common Than You Think

Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline?

Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?

Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1

Taking Action Against RSV: No Child Unprotected

Early Action in Obesity: Transforming Practice, Improving Outcomes